These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 27569291)
21. Clinical pharmacokinetics of metformin. Scheen AJ Clin Pharmacokinet; 1996 May; 30(5):359-71. PubMed ID: 8743335 [TBL] [Abstract][Full Text] [Related]
22. Genetic and Epigenetic Regulation of Organic Cation Transporters. Kölz C; Schaeffeler E; Schwab M; Nies AT Handb Exp Pharmacol; 2021; 266():81-100. PubMed ID: 33674913 [TBL] [Abstract][Full Text] [Related]
23. Influence of Plantago ovata husk (dietary fiber) on the bioavailability and other pharmacokinetic parameters of metformin in diabetic rabbits. Díez R; García JJ; Diez MJ; Sierra M; Sahagun AM; Fernández N BMC Complement Altern Med; 2017 Jun; 17(1):298. PubMed ID: 28592281 [TBL] [Abstract][Full Text] [Related]
24. Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro. Breining P; Jensen JB; Sundelin EI; Gormsen LC; Jakobsen S; Busk M; Rolighed L; Bross P; Fernandez-Guerra P; Markussen LK; Rasmussen NE; Hansen JB; Pedersen SB; Richelsen B; Jessen N Diabetes Obes Metab; 2018 Sep; 20(9):2264-2273. PubMed ID: 29752759 [TBL] [Abstract][Full Text] [Related]
25. Gender-Related Differences in the Expression of Organic Cation Transporter 2 and its Role in Urinary Excretion of Metformin in Rats. Ma YR; Qin HY; Jin YW; Huang J; Han M; Wang XD; Zhang GQ; Zhou Y; Rao Z; Wu XA Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):559-65. PubMed ID: 25876759 [TBL] [Abstract][Full Text] [Related]
26. Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice. Garbarino VR; Santos TA; Nelson AR; Zhang WQ; Smolik CM; Javors MA; Daws LC; Gould GG Pharmacol Res; 2019 Feb; 140():21-32. PubMed ID: 30423430 [TBL] [Abstract][Full Text] [Related]
27. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. Wang DS; Jonker JW; Kato Y; Kusuhara H; Schinkel AH; Sugiyama Y J Pharmacol Exp Ther; 2002 Aug; 302(2):510-5. PubMed ID: 12130709 [TBL] [Abstract][Full Text] [Related]
28. Mapping of biguanide transporters in human fat cells and their impact on lipolysis. Arner P; Kulyté A; Batchelor K; Laurencikiene J; Livingston J; Rydén M Diabetes Obes Metab; 2018 Oct; 20(10):2416-2425. PubMed ID: 29862627 [TBL] [Abstract][Full Text] [Related]
29. SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients. He R; Zhang D; Lu W; Zheng T; Wan L; Liu F; Jia W Diabetes Res Clin Pract; 2015 Jul; 109(1):57-63. PubMed ID: 26004431 [TBL] [Abstract][Full Text] [Related]
30. The Influence of OCT3 and MATE2 Genetic Polymorphisms in Poor Response to Metformin in Type 2 Diabetes Mellitus. Naem AAA; Al-Terehi MN; Ghafil FA; Ataya FS; Batiha GE; Alexiou A; Papadakis M; Welson NN; Hadi NR Endocrinol Diabetes Metab; 2024 Sep; 7(5):e486. PubMed ID: 39086121 [TBL] [Abstract][Full Text] [Related]
31. Metformin inhibits OCT3-mediated serotonin transport in the placenta. Vachalova V; Kumnova F; Synova T; Anandam KY; Abad C; Karahoda R; Staud F Biomed Pharmacother; 2024 Oct; 179():117399. PubMed ID: 39243433 [TBL] [Abstract][Full Text] [Related]
33. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells. Cai H; Zhang Y; Han TK; Everett RS; Thakker DR Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511 [TBL] [Abstract][Full Text] [Related]
34. [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency. Jensen JB; Sundelin EI; Jakobsen S; Gormsen LC; Munk OL; Frøkiær J; Jessen N Diabetes; 2016 Jun; 65(6):1724-30. PubMed ID: 26993065 [TBL] [Abstract][Full Text] [Related]
35. Transport of biguanides by human organic cation transporter OCT2. Sogame Y; Kitamura A; Yabuki M; Komuro S; Takano M Biomed Pharmacother; 2013 Jun; 67(5):425-30. PubMed ID: 23582785 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action. Zhu HJ; Appel DI; Gründemann D; Richelson E; Markowitz JS Pharmacol Res; 2012 Apr; 65(4):491-6. PubMed ID: 22342816 [TBL] [Abstract][Full Text] [Related]
37. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin. Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442 [TBL] [Abstract][Full Text] [Related]
38. Metformin transporter pharmacogenomics: insights into drug disposition-where are we now? Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1149-1159. PubMed ID: 30375241 [TBL] [Abstract][Full Text] [Related]
39. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin. Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861 [TBL] [Abstract][Full Text] [Related]
40. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Shu Y; Brown C; Castro RA; Shi RJ; Lin ET; Owen RP; Sheardown SA; Yue L; Burchard EG; Brett CM; Giacomini KM Clin Pharmacol Ther; 2008 Feb; 83(2):273-80. PubMed ID: 17609683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]